The time is now: role of pragmatic clinical trials in guiding response to global pandemics.
Ontology highlight
ABSTRACT: Along with its heavy toll of morbidity and mortality, the coronavirus disease 2019 (COVID-19) pandemic exposed several limitations of the current global research response. The slow and inefficient process of carrying out traditional randomized clinical trials led regulatory authorities to hastily approve treatments and tests without sufficient evidence of safety and efficacy.We here outline issues with the current research platform, summarize shortcomings of traditional randomized clinical trials particularly apparent at the time of pandemics, and highlight the advantages of pragmatic clinical trials as an alternative to rapidly generate the needed clinical evidence. We further discuss barriers and challenges to pragmatic clinical trials implementation and explore opportunities for researc
SUBMITTER: Almufleh A
PROVIDER: S-EPMC7988242 | biostudies-literature | 2021 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA